Air pollution emerges as a growing concern in risk factors linked to lung cancer deaths

Even though lung and related cancer deaths decreased in the world’s 10 most populous countries from 1990 to 2019, these positive statistics do not address trends in mortality linked to tobacco use, air pollution and asbestos exposure. Those areas need ongoing policy measures and research to further reduce deaths, according to a new study from researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, and collaborating organizations.
Read More

Kidney cancer study identifies factors for exceptional response to immunotherapy

Metastatic clear cell renal cell carcinoma (mccRCC), an aggressive type of kidney cancer, has historically presented limited treatment options. Immune checkpoint inhibitors, a form of immunotherapy, can lead to exceptional, durable responses (when the tumor substantially shrinks for a very long period of time) for some patients with mccRRC, allowing them to live longer with a better quality of life. However, the molecular reasons behind these exceptional responses have not been well defined.
Read More

Alcohol raises colorectal cancer risk while calcium protects, study finds

Researchers from the Cancer Epidemiology Unit at the University of Oxford, along with collaborators from international institutions, found significant associations between diet and colorectal cancer risk. Examining data from 542,778 women in the United Kingdom, the study identified a positive correlation between alcohol consumption and colorectal cancer and a protective role for calcium and dairy-related foods.
Read More

Clinical trial shows ‘Shared Care’ model safe for patients after donor stem cell transplant

Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized follow-up care, traditionally delivered at the center where they received their transplant—often a serious challenge for those who live far away. A large clinical trial by Dana-Farber Cancer Institute investigators shows that patients can fare just as well when they receive some of this care at a local hematology/oncology clinic.
Read More

Combination treatment for liver cancer significantly improves progression-free survival in global trial

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC). This research, led by Josep M. Llovet, MD, Ph.D., Professor of Medicine (Liver Diseases) at the Icahn School of Medicine at Mount Sinai, tested a combination of treatments that could help patients live longer without their cancer getting worse.
Read More

New tool puts reproductive risk for BRCA carriers into perspective

“I just wish someone had told me this was a possibility.” Kara Maxwell distinctly remembers the moment she heard those words eight years ago from the mother of a child with Fanconi anemia (FA). Maxwell met her at a conference focused on the rare, recessive genetic bone marrow disorder that causes myriad medical challenges, including childhood cancer. While survival is improving, the average lifespan for FA is currently only 20 to 30 years.
Read More

Study identifies TBK1 as key to overcoming CAR T resistance

Russell W. Jenkins, MD, Ph.D., a physician investigator in the Krantz Family Center for Cancer Research at the Mass General Cancer Center and an assistant professor of Medicine at Harvard Medical School, is senior author of a new study in Cancer Immunology Research, “TBK1 is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids”.
Read More
Top